Helicobacter-pylori Gastric ulcer. Gastric ulcer
Conditions
Interventions
Intervention 1: Control group: Placebo syrup
It is prepared in NIAK Pharmaceutical Company, which is packaged in bottles completely similar to honey. The placebo will contain water, 0.1% sodium benzoate, 0.1% saccharin and food coloring and the
Licensed by the Food and Drug Administration of the Ministry of Health and Medical Education, with license number 0425-94-S, produced by NIAK Pharmaceutical Company. This syrup contains ingredients of
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 18 to 60 years Helicobacter pylori gastric ulcer positive Urease rapid test
Exclusion criteria
Exclusion criteria: Pregnancy and Breastfeeding Complex gastrointestinal ulcers (ie GU and DU at the same time) History of wound complications (such as bleeding, perforation, pyloric stenosis, and precancerous lesions) Liver or kidney dysfunction and heart failure Other serious illnesses (e.g., severe mental disorders and cancer). History of alcohol consumption.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of gastric ulcer. Timepoint: Before and after the intervention. Method of measurement: Self-declaration.;Ulcer. Timepoint: Before and after the intervention. Method of measurement: Endoscopic observation.;Helicobacter pylori infection. Timepoint: Before and after the intervention. Method of measurement: Urease rapid test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRasool Choopani
Shahid Beheshti University of Medical Sciences
Outcome results
None listed